18 June COVID-19 and Kawasaki Disease: Novel Virus and Novel Case
Veena G. Jones, Marcos Mills, Dominique Suarez, Catherine A. Hogan, Debra Yeh, J. Bradley Segal, Elizabeth L. Nguyen, Gabrielle R. Barsh, Shiraz Maskatia, Roshni Mathew
ABSTRACT
Amid the coronavirus disease 2019 (COVID-19) pandemic, we are seeing widespread disease burden affecting patients of all ages around the world. However, much remains to be understood as how clinicians, epidemiologists, and researchers are working to describe and characterize the disease process while caring for patients on the front lines.
We describe the case of a 6-month-old baby admitted and diagnosed with classic Kawasaki disease, who also tested positive for COVID-19 in the context of fever and minimal respiratory symptoms.
The patient was treated according to treatment guidelines, with intravenous immunoglobulin and high doses of aspirin, and subsequently deferred with resolution of clinical symptoms.
The patient's initial echocardiogram was normal and she was discharged within 48 hours after completing the intravenous immunoglobulin infusion, with instructions to quarantine her home for 14 days from the date of her positive test results for COVID-19.
Further study of the clinic is justified by the presentation of pediatric COVID-19 and the possible association with Kawasaki disease, as are the indications for COVID-19 testing in the febrile infant.